LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in September.

Morgan Stanley 22nd Annual Global Healthcare ConferenceWednesday, September 4, 2024New York Marriott Marquis, New York, NYDavid Roberts, President, will present at 5:35 PM EST

Barrington Research Fall Investment Conference (Virtual)Thursday, September 12, 2024George W. LeMaitre, Chairman & CEO, is scheduled to host a series of 1x1 meetings

Cantor Fitzgerald 2024 Global Healthcare ConferenceThursday, September 19, 2024InterContinental New York Barclay Hotel, New York, NYDavid Roberts, President, will present at 8:00 AM EST

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

Contact: 
LeMaitre Vascular, Inc. 
Sandra Millar 
+1-781-425-1686 
smillar@lemaitre.com
LeMaitre Vascular (NASDAQ:LMAT)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025 Haga Click aquí para más Gráficas LeMaitre Vascular.
LeMaitre Vascular (NASDAQ:LMAT)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025 Haga Click aquí para más Gráficas LeMaitre Vascular.